From: Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer
Characteristics | N = 128 (%) |
---|---|
Sex | Â |
   Male | 70 (54.7%) |
   Female | 58 (45.3%) |
Race | Â |
   Caucasians | 120 (93.8%) |
   Non-Caucasians | 8 (6.2%) |
Age | Â |
   Mean (SD) | 64.2 (10.7) |
Smoking status | Â |
   Never | 11 (8.6%) |
   Former | 64 (50.0%) |
   Current | 53 (41.4%) |
Pack-years of smoking (a) | Â |
   Mean (SD) | 51.4 (27.0) |
Family history of lung cancer | Â |
   No | 87 (68.0%) |
   Yes | 41 (32.0%) |
Zubrod Performance status | Â |
   Without symptom | 87 (68.0%) |
   With symptom | 41 (32.0%) |
Weight loss (b) | Â |
   No | 110 (85.9%) |
   Yes | 18 (14.1%) |
Vital status | Â |
   Alive | 49 (38.3%) |
   Dead | 79 (61.7%) |
Pathologic TNM stage | Â |
   I | 75 (58.6%) |
   II | 31 (24.2%) |
   IIIA | 22 (17.2%) |
Histology | Â |
   Adenocarcinoma | 77 (60.2%) |
   Squamous | 39 (30.5%) |
   Large cell | 5 (3.9%) |
   Others | 7 (5.5%) |
Grade | Â |
   Well differentiation | 3 (2.3%) |
   Moderate differentiation | 48 (37.5%) |
   Poor differentiation | 77 (60.2%) |
Receiving adjuvant chemotherapy | Â |
   No | 109 (85.2%) |
   Yes | 19 (14.8%) |
MCM2 | Â |
   Low | 49 (38.3%) |
   High | 79 (61.7%) |
Ki-67 | Â |
   Low | 28 (21.9%) |
   High | 100 (78.1%) |
Gelsolin level | Â |
   Low | 86 (67.2%) |
   High | 42 (32.8%) |